Abstract
Sheep anti‐rat‐kidney serum and rabbit anti‐rat‐kidney serum were utilized in a number of biological studies in order to clarify some of the qualitative and quantitative effects of this antiserum. The teratogenic factor or factors present in these antisera can be characterized as follows: The antiserum is (1) ineffective when administered by the oral route; (2) the antiserum is teratogenic when administered by the intravenous, intraperitoneal, subcutaneous or intrauterine route; (3) more effective by the intravenous and intraperitoneal route than by the subcutaneous route and (4) no more effective when injected into the uterine lumen of a pregnant rat than when given intravenously; (5) uterine vascular clamping experiments and injection of the antiserum during the preimplantation period indicate that the teratogenic milieu persists for days following the administration of the antiserum; (6) the antiserum can be considered a classical teratogenic agent because it produces a different spectrum of malformations on different days of gestation and concomitant fetal mortality and growth retardation; although stage specificity is not as dramatic with the antiserum as with irradiation; (7) although the exact mechanism of teratogenesis is not understood, it was pointed out that fluorescent localization data and the experiments reported herein indicate a similarity between teratogenic antiserum and trypan blue; (8) the importance of yolk sac pathology during the period of differentiation is discussed as it pertains to normal embryology, teratogenesis and the utilization of animals in drug testing programs for the evaluation of teratogenic effects.

This publication has 8 references indexed in Scilit: